Clinical Trials Browser

Phase 3 × INDUSTRY × avapritinib × Clear all

NCT03465722 2022-10-06

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Phase 3 Completed

476 enrolled 14 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors